TAU-IMMUNTHERAPIE

European patent · EP2970453 · In force

Register entry

Publication number
EP2970453
Application number
EP14778358
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 12, 2014
Published
Jan 20, 2016
Granted
Dec 4, 2019
Protection ends at the latest
Mar 11, 2034
Next annual fee due
Mar 31, 2027
IPC classes
C07K 16/18 (2006.01)
A61K 39/395 (2006.01)
A61P 25/28 (2006.01)
Priority
US 201361780624 P 13.03.2013
US 201361800382 P 15.03.2013
PCT application
PCT/US2014/025044 12.03.2014
PCT publication
WO2014/165271 09.10.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. May 16, 2022

    Address changed

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 16.05.2022

  6. Jan 18, 2020

    Agent entered

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich

    Published in Swissreg on 18.01.2020

  7. Dec 4, 2019

    Granted

    Published in Swissreg on 04.12.2019

Parties

Inventor

SEUBERT, Peter

San Francisco, CA 94114, US

BARBOUR, Robin

Walnut Creek, CA 94598, US

LIU, Yue

Foster City, CA 94404, US

DOLAN, Philip James III

Foster City, CA 94404, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.